195 filings
Page 6 of 10
6-K
NCNA
NuCana plc
2 Jun 20
NuCana plc Notice of Annual General Meeting Thursday 25 June 2020 at 11.00am Venue Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT, UK
4:11pm
6-K
NCNA
NuCana plc
19 May 20
Unaudited Condensed Consolidated Statements of Operations
4:19pm
6-K
NCNA
NuCana plc
18 May 20
NuCana Announces theRe-Opening of Enrollment in Multiple Clinical Studies
7:27am
6-K
NCNA
NuCana plc
15 May 20
NuCana to Present Two Abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2020
7:11am
6-K
NCNA
NuCana plc
5 May 20
NuCana AnnouncesRe-Opening of Global Phase III Study of Acelarin
4:46pm
6-K
NCNA
NuCana plc
2 Apr 20
NuCana Provides Update on Impact ofCOVID-19 on Clinical Studies
4:25pm
20-F
2019 FY
NCNA
NuCana plc
Annual report (foreign)
10 Mar 20
5:01pm
6-K
NCNA
NuCana plc
10 Mar 20
Confirmed Complete Response and Two Partial Responses Achieved
4:09pm
SC 13G/A
NCNA
NuCana plc
10 Mar 20
NuCana / Capital International Investors ownership change
1:48pm
6-K
NCNA
NuCana plc
4 Mar 20
NuCana Receives Positive Opinion for Orphan Drug Designation in the European
7:22am
SC 13G/A
NCNA
NuCana plc
14 Feb 20
NuCana plc
4:03pm
SC 13G
Harvard Management Co Inc
14 Feb 20
NuCana plc
4:01pm
SC 13G
Capital International Investors
14 Feb 20
NuCana plc
12:07pm
SC 13G/A
NCNA
NuCana plc
14 Feb 20
Beneficial ownership report (amended)
12:03pm
SC 13G/A
Wood Christopher B
14 Feb 20
Beneficial ownership report (amended)
12:00am
SC 13D/A
NCNA
NuCana plc
12 Feb 20
Beneficial ownership report (amended)
12:00am
6-K
NCNA
NuCana plc
27 Jan 20
NuCana Announces First Patients Dosed in Both US and Europe in Phase III
7:20am
SC 13G/A
NCNA
NuCana plc
16 Jan 20
NuCana plc
5:10pm
6-K
NCNA
NuCana plc
27 Dec 19
Current report (foreign)
4:06pm
6-K
NCNA
NuCana plc
13 Nov 19
Unaudited Condensed Consolidated Statements of Operations
5:03pm